The incorporation of clinical guidelines of pharmacogenomics in Latin America
Author
dc.contributor.author
Quiñones Sepúlveda, Luis
Author
dc.contributor.author
Lares Asseff, Ismael
Admission date
dc.date.accessioned
2019-05-29T13:59:12Z
Available date
dc.date.available
2019-05-29T13:59:12Z
Publication date
dc.date.issued
2017
Cita de ítem
dc.identifier.citation
En: Pharmacogenomics in Latin America: Challenges and Opportunities, Edition: 1st, 2017. Chapter 1, pp.1 - 10
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/169164
Abstract
dc.description.abstract
In Latin America the Pharmacogenetics and Pharmacogenomics areas are recently emerging
fields and the main focus of the research is to evaluate ethnic differences to apply adapted
guidelines to manage personalized pharmacotherapy. Large differences between countries in the
awareness and in the use of pharmacogenomic testing are presumed, but are not well assessed to
date. In this chapter, we present the efforts to investigate variability in drug response using the
molecular approaches and the limitations to apply pharmacogenomics test in clinical centers and
hospitals.